´ëÇÑ°£ÇÐȸ The Liver Week 2024 Day 2 : 2024-06-28
±³À°ÀÏÀÚ : 2024-06-28
±³À°Àå¼Ò : ¿öÄ¿Èú¼¿ïÈ£ÅÚ ROOM 1~10
±³À°ÁÖÁ¦ : The Liver Week 2024 Day 2
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-707-0091
À̸ÞÀÏ : kasl@kams.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 31 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 21,000¿ø
ºñ°í [TLW]Member-150,000/ Resident, Trainee, Fellow, Researcher, Army Doctor, Nurse, or Others-90,000/ Resident, Trainee, Army Doctor + Private Hands-On Ultrasound Course on June 27-140,000/ Non-Member, Healthcare Professional-180,000 International Delegate-USD 150 Travel Award Recipient-USD 40 [PG]Member-60,000/ Resident, Trainee, Fellow, Researcher, Army Doctor, Nurse, or Others-40,000 Non-Member, Healthcare Professional-70,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 09:10~09:30 Standardized and Individualized Criteria for Cessation of Antiviral Therapy in Chronic Hepatitis B Hyung Joon Yim(Korea Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 09:30~09:50 Monitoring and Prevention of Reactive and Progressive Properties of Occult Hepatitis B Virus Infection Jeong Won Jang(The Catholic Univ. of Korea)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 09:50~10:10 Precision Strategy for HCC Surveillance after Curing Hepatitis C: Debates across Guidelines Tatsuya Kanto(National Center for Global Health and Medicine, Japan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 10:10~10:30 Experimental Drugs and Therapeutic Endpoints of Chronic Hepatitis D Maria Buti(Univ. of Barcelona, Spain)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 11:10~11:40 The Journey of a Hepatologist W. Ray Kim(Stanford Univ., USA)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 11:40~11:55 Transarterial Radioembolization versus Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma with Portal Vein Thrombosis Youngsu Park(Seoul National University)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 11:55~12:10 LI-RADS imaging diagnosis of hepatocellular Carcinoma in noncirrhotic patients with chronic hepatitis C: a multicenter development and validation cohort Ha Il Kim(Hanyang University)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 12:10~12:25 Anatomical Risk Factors for Portal Vein Complications Following Right Hepatectomy in Living Donors: Analysis of Results from 4720 Cases Young-In Yoon(University of Ulsan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 12:25~12:40 Persistent systemic inflammation is important driver of acute-on-chronic liver failure and organ failure development Do Seon Song(The Catholic University of Korea)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 13:30~13:50 Temporal and Spatial Cancer Evolution of Dysplastic Nodules in the Liver Ju Hyun Shim(Univ. of Ulsan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 13:50~14:10 Genomic and Epigenetic Clues to Persistent Risk of HCC after Curing Hepatitis C Yujin Hoshida(Univ. of Texas Southwestern Medical Center, USA)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 14:10~14:30 Clinical and Subclinical Risk Factors of Non-Viral HCC: Is It Preventable? Do Young Kim(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 14:30~14:50 Guidelines and Evidence-Based Recommendations for Sequential Systemic Therapy of HCC Grace L. Su(Univ. of Michigan, USA)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 14:50~15:10 Genetic Vulnerabilities of Alcohol-Related Hepatitis and HCC in the East and West Jean-Charles Nault(Sorbonne Université, France)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 15:10~15:30 Biomarkers in Alcohol-Related Liver Diseases Pierre-Emmanuel Rautou(Université Paris-Cité, France)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 15:30~15:50 Principles of and Debates on Indication and Duration of Use of Corticosteroids in Severe Alcoholic Hepatitis Young Kul Jung(Korea Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 15:50~16:10 Optimal Timing of Liver Transplantation in Severe Alcoholic Hepatitis Julie K. Heimbach(Mayo Clinic, USA)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 16:30~16:50 Approach to Abnormal Liver Blood Tests of Inpatients and Outpatients Myeong Jun Song(The Catholic Univ. of Korea)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 16:50~17:10 Adverse Events of Systemic Therapy in HCC Patients: Assessment and Education Eun Ju Cho(Seoul National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 17:10~17:30 Role of Artificial Intelligence to Assist Clinical Research Coordinators Hyun Suk Park(Asan Medical Center)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 17:30~17:50 Current Status and Prospects of Site Management Organization (SMO) in Clinical Trials Seong Jae Kim(Gyeongsang National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 09:10~09:30 Current and Future Perspective of Spatial Omics in HCC Junil Kim(Soongsil Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 09:30~09:50 Precision Medicine for Designing Future Clinical Trials for Immuno-Oncology Treatment Sun Young Yim(Korea Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 09:50~10:10 Radiogenomics and Radiomics in Liver Cancers Hyungjin Rhee(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 10:10~10:30 Discovery of Blood Biomarkers for Immune-Based Treatments of HCC: Protein vs. cfDNA/snRNA Hye Won Lee(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 13:30~13:50 Trailblazing First-Line Therapies: Which Immuno-Oncology Therapy Would be the Best for Advanced HCC? Yong-Han Paik(Sungkyunkwan Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 13:50~14:10 Navigating the Post-Immunotherapy: Second-Line Options for HCC Masatoshi Kudo(Kindai Univ., Japan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 14:10~14:30 Overcoming Resistance and Relapse against HCC Immunotherapy Pil Soo Sung(The Catholic Univ. of Korea)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 14:30~14:50 Predictive Biomarker Research of Combination Immunotherapy: Current Status and Future Perspectives Takahiro Kodama(Osaka Univ., Japan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 14:50~15:10 Maximizing Indication and Safety in Living Donor Liver Transplantation for HCC Pyoung Jae Park(Korea Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 15:10~15:30 Making an Impact with Radioembolization for HCC Management Hyo-Cheol Kim(Seoul National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 15:30~15:50 Harnessing the Power of Radiotherapies for HCC Treatment Jeong Il Yu(Sungkyunkwan Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 15:50~16:10 Evolving Strategies: Treatment Patterns of HCC from Korean Claims Data Ji Won Han(The Catholic Univ. of Korea)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 16:10~16:30 HCC in Korea: The Past, Present and the Future Hae Lim Lee(The Catholic Univ. of Korea)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 09:10~09:30 Attributes and Principles for Better Practice Guidelines: An Experience with KLCA-NCC Korea Practice Guidelines for HCC Joong-Won Park(Myongji Hospital, Hanyang Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 09:30~10:00 AASLD Guidelines on Clinical Assessment and Management of MASLD Rohit Loomba(Univ. of California San Diego, USA)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 10:00~10:30 EASL Guidelines on Vascular Liver Disease Pierre-Emmanuel Rautou(Université Paris-Cité, France)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 13:30~13:50 Clinical Data Based on Old NAFLD and New MASLD: Shared vs. Separated Mark Muthiah(National Univ. Hospital, Singapore)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 13:50~14:10 Diagnostic Criteria and Clinical Impact of Steatotic Liver Disease Sub-Classification Byoung Kuk Jang(Keimyung Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 14:10~14:30 Pathophysiology-Based Treatment Targets and Successful Trials in MASH Mi Na Kim(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 14:30~14:50 Tumor Immunity and Immunotherapeutic Susceptibility of Steatotic HCC Tetsuo Takehara(Osaka Univ., Japan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 14:50~15:10 Different Definitions and Prognostic Stratification of Acute-on-Chronic Liver Failure Rakhi Maiwall(Institute of Liver and Biliary Sciences, India)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 15:10~15:30 Respiratory Support in Acute-on-Chronic Liver Failure Jin Won Huh(Univ. of Ulsan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 15:30~15:50 Management of Organ Failure and Infection in Critically-ill Patients with Acute-on-Chronic Liver Failure Guadalupe Garcia-Tsao(Yale Univ., USA)
Åä·Ð 06¿ù 28ÀÏ ROOM 3 15:50~16:10 Panel Discussion ()
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 09:10~09:30 Patient Selection and Result for Unresectable Hepatic Metastasis from Colorectal Cancer Jongman Kim(Sungkyunkwan Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 09:30~09:50 Perihilar Cholangiocarcinoma: Current Strategy and Future Directions Julie K. Heimbach(Mayo Clinic, USA)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 09:50~10:10 The Role of Liver Transplantation for Intrahepatic Cholangiocarcinoma Ho Joong Choi(The Catholic Univ. of Korea)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 10:10~10:30 HCC with Portal Vein Tumor Thrombosis Kwangho Yang(Pusan National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 11:40~12:10 Long-Term Follow-Up and Support Programs for Living Liver Donors in Korea YoungRok Choi(Seoul National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 12:10~12:25 Current Status of Living Liver Donor Management at Low Volume Center Min Kyung Nam(Hanyang Univ. Seoul Hospital)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 12:25~12:40 Considerations for Liver Donor Management Ji Eun Lee(Severance Hospital)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 13:30~13:50 De Novo Malignancies: Long-Term Experience and Surveillance Strategy Woo-Hyoung Kang(Univ. of Ulsan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 13:50~14:10 How to Deal with Chronic Disease after Liver Transplantation Jae Geun Lee(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 14:10~14:30 Treading a Tightrope: A Strategy that Provides Minimal Immune Suppression while Reducing Rejection and Graft Fibrosis Sang Hoon Lee(Sungkyunkwan Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 14:30~14:50 Physical Therapy and Exercise to Improve Quality of Life after Liver Transplantation Won Kim(Univ. of Ulsan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 14:50~15:10 Seoul National University Hospital Experience Kwang-Woong Lee(Seoul National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 15:10~15:30 Samsung Medical Center Experience Gyu-seong Choi(Sungkyunkwan Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 15:30~15:50 Dr. Rela Institute Experience Ashwin Rammohan(Rela Hospital, India)
Åä·Ð 06¿ù 28ÀÏ ROOM 4 15:50~16:10 Panel Discussion ()
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 07:30~08:00 Before and After TIPS: Practical Insights from Real-World Experience Min Kyung Park(Seoul National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 08:00~08:15 Tips for Getting an Acceptance from AASLD Journals Elliot B. Tapper(Univ. of Michigan, USA)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 08:15~08:30 Tips for Getting an Acceptance from CMH Won Kim(Seoul National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 08:30~08:45 Hepatology Editor's Picks: Noticeable Publications in 2023-2024 Yujin Hoshida(Univ. of Texas Southwestern Medical Center, USA)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 08:45~09:00 CMH Editor's Picks: Noticeable Publications in 2023-2024 Seung Up Kim(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 6 08:00~08:20 Past and Present of LI-RADS in HCC Diagnosis Sunyoung Lee(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 6 08:20~08:40 LI-RADS: It Is Time to Focus on Prognosis Subin Heo(Univ. of Ulsan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 6 08:40~09:00 Future Perspectives and New Challenges in LI-RADS Bin Song(Sichuan Univ., China)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 08:00~08:25 Understanding Spatial Transcriptomics in Hepatology: From Sample Preparation to Application Kwon Joong Na(Seoul National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 08:25~08:50 Emerging Organoid Technologies to Apply for Precision Medicine in Hepatology Myung Jin Son(Korea Research Institute of Bioscience and Biotechnology)
Åä·Ð 06¿ù 28ÀÏ ROOM 7 08:50~09:00 Discussion ()
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 09:10~09:40 Hepatocellular Carcinoma in RNA Biology Jungwook Hwang(Hanyang Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 09:40~10:05 Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of HCC Kyun-Hwan Kim(Sungkyunkwan Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 10:05~10:30 Modulation of Amino Acid Metabolism as a Therapeutic Target of Liver Cancer Keun-Gyu Park(Kyungpook National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 13:30~13:50 Practical Approach for Causal Inference Danbee Kang(Sungkyunkwan Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 13:50~14:10 Advanced Survival Analysis Seo Young Park(Korea National Open Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 14:10~14:30 Development of Clinical Prediction Models Sehee Kim(Univ. of Ulsan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 14:30~14:50 Various Model Performance Measures Seungbong Han(Korea Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 14:50~15:10 Common Data Model (CDM) for Observational Research Seng Chan You(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 15:10~15:30 AI's Role in Diagnosis and Prognosis Kyu-Hwan Jung(Sungkyunkwan Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 15:30~15:50 Big Data in Healthcare: Research and Applications So-Ryoung Lee(Seoul National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 15:50~16:10 Guide for Radiomics Study to Clinical Researchers Hyo Jung Park(Univ. of Ulsan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 09:10~09:20 Case Presentation 1. (Internal Medicine) Yuri Cho(National Cancer Center)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 09:20~09:30 Case Presentation 2. (Surgery) Jae Geun Lee(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 09:30~09:50 Endoscopic and Percutaneous Biliary Decompression Sang Hyub Lee(Seoul National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 09:50~10:10 Transarterial Intervention Treatments Dongho Hyun(Sungkyunkwan Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 10:10~10:30 Liver Resection and Transplantation Xiao Xu(Zhejiang Univ., China)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 13:30~13:50 °£¾Ï ÀûÁ¤¼ºÆò°¡ ¹× ÇâÈÄ°úÁ¦ Nam Ryoung Kim(Health Insurance Review & Assessment Service)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 13:50~14:10 Ç×¾ÏÁ¦ ¾àÁ¦±Þ¿©±âÁØ Mi Young Kang(Health Insurance Review & Assessment Service)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 14:10~14:30 Management Model after Screening for Viral Hepatitis B and C in Korea Young Chang(Soonchunhyang Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 14:30~14:50 Local Government-Based Hepatitis C Elimination Project: Jeollanam-do Performance Report Min-Ho Shin(Chonnam National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 14:50~15:10 Epidemiologic and Genetic Landscapes of Polycystic Liver Disease Beom Kyung Kim(Yonsei Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 15:10~15:30 Radiological Diagnosis for Cystic Liver Disease Seung Baek Hong(Pusan National Univ.)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 15:30~15:50 EUS-Guided or Percutaneous Therapies for Cystic Liver Disease Dong Wan Seo(Univ. of Ulsan)
±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 15:50~16:10 Surgical Treatments of Large Hepatic Cysts Seoung Yoon Rho(Yonsei Univ.)